Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Tien

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Leukemia|October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDSD Inoue, J Kitaura, H Matsui, et al.
Leukemia|February 20, 2009
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patientsW-C Chou, C-Y Chen, H-A Hou, et al.
British Journal of Cancer|September 1, 2011
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesC-L Cheng, H-A Hou, J-Y Jhuang, et al.
Leukemia|November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaW-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
Leukemia|April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Leukemia|October 8, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Leukemia|October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDSD Inoue, J Kitaura, H Matsui, et al.
Leukemia|February 20, 2009
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patientsW-C Chou, C-Y Chen, H-A Hou, et al.
British Journal of Cancer|September 1, 2011
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesC-L Cheng, H-A Hou, J-Y Jhuang, et al.
Leukemia|November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaW-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
Leukemia|April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Leukemia|October 8, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Pageof 12